Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Ferroportin

Ferroportin is a transmembrane protein primarily responsible for the exocytosis of intracellular iron ions. Ferroportin plays a key role in intestinal epithelial cells, macrophages, and hepatocytes, and has been associated with a variety of disorders of iron metabolism disorders and infertility, such as hemochromatosis and iron deficiency anemia.

Vamifeport
VIT-2763
T395202095668-10-1
Vamifeport (VIT-2763) is a novel orally active inhibitor that targets iron transport proteins and reduces markers of hemolysis in the SCD Townes model.VIT-2763 improves anemia and erythropoiesis, ameliorates vascular inflammation, and can be studied in β-thalassemia.
  • $67
In Stock
Size
QTY
Ferroportin-IN-1
T629542443432-65-1
Ferroportin-IN-1 is an inhibitor of the iron transport protein Ferroportin, which regulates cellular iron efflux and metabolism to study diseases caused by iron-modulating deficiencies or disorders of iron metabolism, used in metabolism studies such as thalassemia, sickle cell disease, and hemochromatosis.
  • $293
In Stock
Size
QTY
Fursultiamine
Judolor, Diteftin, Alinamin F
T4552804-30-8
Fursultiamine (Alinamin F) is a disulfide derivative of thiamine, or an allithiamine. It has potential uses in the treatment of vitamin B1 deficiency.
  • $35
In Stock
Size
QTY
Hepcidin antagonist-1
T61144338965-09-6In house
Hepcidin antagonist-1 is an iron-modulating antagonist.Hepcidin antagonist-1 can be used to study metabolic disorders such as iron-deficiency diseases and anemia.
  • $198 TargetMol
In Stock
Size
QTY
DMT1 blocker 1
T110631354790-56-9In house
DMT1 blocker 1 is a blocker of divalent metal transporter 1 (DMT1) with IC50 of 0.64 μM, which is expected to block the absorption of iron by intestinal cells in vivo.
  • $98
In Stock
Size
QTY
DMT1 blocker 2
T110641062648-63-8
DMT1 blocker 2, compound 12f, is a direct inhibitor of divalent metal transporter 1 (DMT1) with an IC50 hydrogen peroxide value of 0.83, which is expected to block iron uptake by intestinal epithelial cells in vivo.
  • $84
In Stock
Size
QTY
LY2928057
LY 2928057
T77383
LY2928057 is a humanized monoclonal antibody targeting the iron transporter SLC40A1, an iron-regulatory inhibitor used in cardiovascular disease research.
  • $372
In Stock
Size
QTY
Pyrimidinone 8
T20504265004-42-4
Pyrimidinone 8 is a reversible, linear non-competitive inhibitor of divalent metal transporter 1 (DMT1) with a Ki of 20 μM (hDMT1). It does not affect the surface expression of hDMT1 and is not influenced by extracellular pH. Pyrimidinone 8 inhibits hDMT1-mediated iron uptake, with an IC50 of 13.8 μM.
  • Inquiry Price
10-14 weeks
Size
QTY
Anti-SLC40A1 Antibody
T9901A-1415
Anti-SLC40A1 Antibody is a human-derived antibody expressed in CHO cells, targeting SLC40A1, with a predicted molecular weight (MW) of 150 kDa.
    Inquiry
    Inquiry
    Anti-Hepcidin/HAMP Antibody
    T9901A-1412
    Anti-Hepcidin/HAMP Antibody is a human-derived antibody produced in CHO cells, targeting Hepcidin/HAMP. It features a huIgG1 heavy chain and a huλ light chain, with a predicted molecular weight (MW) of 145 kDa. The isotype control for this antibody can be referenced as HumanIgG1kappa, Isotype Control.
      Inquiry
      Inquiry
      Rusfertide
      PTG-300
      TP26181628323-80-7
      Rusfertide, a peptide mimetic of natural hepcidin, targets and degrades ferroportin, thereby reducing serum iron and transferrin saturation, which helps regulate red blood cell production. It ameliorates conditions such as polycythemia vera, β-thalassemia, and hereditary hemochromatosis [1] [2].
      • Inquiry Price
      Inquiry
      Size
      QTY
      DS28120313
      T151702146177-09-3
      DS28120313 is an oral inhibitor of hepcidin production (IC50: 0.093 μM).
      • $854
      6-8 weeks
      Size
      QTY